Apyx Medical Stock Cash Flow From Operations

APYX Stock

USD 1.20 0.02 1.69%

Apyx Medical fundamentals help investors to digest information that contributes to Apyx Medical's financial success or failures. It also enables traders to predict the movement of Apyx Stock. The fundamental analysis module provides a way to measure Apyx Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Apyx Medical stock.

Short Long Term Debt Total Total Assets

This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Apyx Medical Company Cash Flow From Operations Analysis

Apyx Medical's Operating Cash Flow reveals the quality of a company's reported earnings and is calculated by deducting company's income taxes from earnings before interest, taxes, and depreciation (EBITDA). In other words, Operating Cash Flow refers to the amount of cash a firm generates from the sales or products or from rendering services. Operating Cash Flow typically excludes costs associated with long-term investments or investment in marketable securities and is usually used by investors or analysts to check on the quality of a company's earnings.

Operating Cash Flow

EBITDA

-

Taxes

More About Cash Flow From Operations | All Equity Analysis

Current Apyx Medical Cash Flow From Operations

(5.25 M)

Most of Apyx Medical's fundamental indicators, such as Cash Flow From Operations, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Apyx Medical is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Apyx Cash Flow From Operations Driver Correlations

Understanding the fundamental principles of building solid financial models for Apyx Medical is extremely important. It helps to project a fair market value of Apyx Stock properly, considering its historical fundamentals such as Cash Flow From Operations. Since Apyx Medical's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Apyx Medical's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Apyx Medical's interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Good Will	Total Liab	Total Current Assets	Short Term Debt	Intangible Assets	Common Stock	Property Plant Equipment	Long Term Debt	Net Tangible Assets	Long Term Debt Total	Capital Surpluse	Deferred Long Term Liab	Short Long Term Debt	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.81	0.19	-0.6	0.15	0.67	0.66	-0.45	0.5	1.0	0.54	-0.72	-0.05	0.32	0.66	0.88	-0.58	0.71	-0.69	-0.89	0.92	0.96	0.43
Total Stockholder Equity	0.81		0.43	-0.77	0.63	0.29	0.45	-0.31	-0.1	0.82	0.56	-0.56	0.06	0.23	0.29	0.95	-0.56	0.5	-0.58	-0.74	0.89	0.82	-0.12
Current Deferred Revenue	0.19	0.43		-0.51	0.35	0.03	0.0	-0.26	-0.31	0.21	0.17	0.02	-0.03	0.17	-0.12	0.27	0.08	0.15	-0.06	-0.07	0.26	0.17	-0.46
Net Debt	-0.6	-0.77	-0.51		-0.46	-0.35	-0.48	0.19	0.11	-0.61	-0.41	0.51	-0.16	-0.17	-0.48	-0.72	0.4	-0.44	0.46	0.61	-0.67	-0.6	0.2
Retained Earnings	0.15	0.63	0.35	-0.46		-0.49	-0.27	0.08	-0.68	0.16	0.34	-0.01	0.09	-0.12	-0.4	0.51	-0.1	-0.3	-0.03	-0.07	0.42	0.29	-0.67
Accounts Payable	0.67	0.29	0.03	-0.35	-0.49		0.82	-0.35	0.71	0.67	0.25	-0.67	0.04	0.24	0.87	0.41	-0.42	0.82	-0.59	-0.74	0.46	0.55	0.62
Net Receivables	0.66	0.45	0.0	-0.48	-0.27	0.82		-0.3	0.45	0.66	0.19	-0.73	0.11	0.27	0.87	0.53	-0.57	0.83	-0.66	-0.82	0.51	0.56	0.4
Good Will	-0.45	-0.31	-0.26	0.19	0.08	-0.35	-0.3		-0.28	-0.38	-0.2	-0.14	0.78	-0.72	-0.3	-0.17	0.05	-0.18	0.12	0.16	-0.15	-0.22	-0.06
Total Liab	0.5	-0.1	-0.31	0.11	-0.68	0.71	0.45	-0.28		0.48	0.09	-0.39	-0.18	0.21	0.69	0.1	-0.14	0.49	-0.33	-0.41	0.25	0.41	0.92
Total Current Assets	1.0	0.82	0.21	-0.61	0.16	0.67	0.66	-0.38	0.48		0.54	-0.77	0.03	0.24	0.65	0.9	-0.6	0.72	-0.71	-0.9	0.94	0.97	0.42
Short Term Debt	0.54	0.56	0.17	-0.41	0.34	0.25	0.19	-0.2	0.09	0.54		-0.3	-0.06	0.21	0.21	0.56	-0.4	0.28	-0.38	-0.47	0.59	0.57	0.12
Intangible Assets	-0.72	-0.56	0.02	0.51	-0.01	-0.67	-0.73	-0.14	-0.39	-0.77	-0.3		-0.58	0.27	-0.68	-0.76	0.63	-0.71	0.71	0.88	-0.77	-0.8	-0.4
Common Stock	-0.05	0.06	-0.03	-0.16	0.09	0.04	0.11	0.78	-0.18	0.03	-0.06	-0.58		-0.82	-0.02	0.24	-0.38	0.19	-0.19	-0.2	0.18	0.15	-0.04
Property Plant Equipment	0.32	0.23	0.17	-0.17	-0.12	0.24	0.27	-0.72	0.21	0.24	0.21	0.27	-0.82		0.3	0.06	0.06	0.32	-0.17	-0.2	0.11	0.1	0.18
Long Term Debt	0.66	0.29	-0.12	-0.48	-0.4	0.87	0.87	-0.3	0.69	0.65	0.21	-0.68	-0.02	0.3		0.41	-0.33	0.72	-0.61	-0.77	0.47	0.56	0.58
Net Tangible Assets	0.88	0.95	0.27	-0.72	0.51	0.41	0.53	-0.17	0.1	0.9	0.56	-0.76	0.24	0.06	0.41		-0.67	0.58	-0.66	-0.84	0.97	0.94	0.1
Long Term Debt Total	-0.58	-0.56	0.08	0.4	-0.1	-0.42	-0.57	0.05	-0.14	-0.6	-0.4	0.63	-0.38	0.06	-0.33	-0.67		-0.61	0.5	0.62	-0.54	-0.57	-0.28
Capital Surpluse	0.71	0.5	0.15	-0.44	-0.3	0.82	0.83	-0.18	0.49	0.72	0.28	-0.71	0.19	0.32	0.72	0.58	-0.61		-0.69	-0.84	0.6	0.62	0.56
Deferred Long Term Liab	-0.69	-0.58	-0.06	0.46	-0.03	-0.59	-0.66	0.12	-0.33	-0.71	-0.38	0.71	-0.19	-0.17	-0.61	-0.66	0.5	-0.69		0.81	-0.7	-0.71	-0.35
Short Long Term Debt	-0.89	-0.74	-0.07	0.61	-0.07	-0.74	-0.82	0.16	-0.41	-0.9	-0.47	0.88	-0.2	-0.2	-0.77	-0.84	0.62	-0.84	0.81		-0.87	-0.88	-0.43
Net Invested Capital	0.92	0.89	0.26	-0.67	0.42	0.46	0.51	-0.15	0.25	0.94	0.59	-0.77	0.18	0.11	0.47	0.97	-0.54	0.6	-0.7	-0.87		0.98	0.24
Net Working Capital	0.96	0.82	0.17	-0.6	0.29	0.55	0.56	-0.22	0.41	0.97	0.57	-0.8	0.15	0.1	0.56	0.94	-0.57	0.62	-0.71	-0.88	0.98		0.37
Capital Stock	0.43	-0.12	-0.46	0.2	-0.67	0.62	0.4	-0.06	0.92	0.42	0.12	-0.4	-0.04	0.18	0.58	0.1	-0.28	0.56	-0.35	-0.43	0.24	0.37

Click cells to compare fundamentals

Operating Cash Flow shows the difference between reported income and actual cash flows of the company. If a firm does not have enough cash or cash equivalents to cover its current liabilities, then both investors and management should be concerned about the company having enough liquid resources to meet current and long term debt obligations.

Competition

Predict Apyx Medical

Total Cash From Operating Activities Over Time

Apyx Discontinued Operations

Discontinued Operations

88.75 Million

At this time, Apyx Medical's Discontinued Operations is fairly stable compared to the past year.

In accordance with the recently published financial statements, Apyx Medical has (5.25 Million) in Cash Flow From Operations. This is 101.0% lower than that of the Health Care Equipment & Supplies sector and 101.44% lower than that of the Health Care industry. The cash flow from operations for all United States stocks is 100.54% higher than that of the company.

Apyx Cash Flow From Operations Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Apyx Medical's direct or indirect competition against its Cash Flow From Operations to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Apyx Medical could also be used in its relative valuation, which is a method of valuing Apyx Medical by comparing valuation metrics of similar companies.

Apyx Medical is currently under evaluation in cash flow from operations category among its peers.

Apyx Fundamentals

	Return On Equity	-1.1
	Return On Asset	-0.22
	Profit Margin	(0.58) %
	Operating Margin	(0.46) %
	Current Valuation	46.73 M
	Shares Outstanding	34.64 M
	Shares Owned By Insiders	17.98 %
	Shares Owned By Institutions	40.52 %
	Number Of Shares Shorted	243.91 K
	Price To Earning	4.04 X
	Price To Book	2.76 X
	Price To Sales	0.83 X
	Revenue	52.35 M
	Gross Profit	29.13 M
	EBITDA	(19.26 M)
	Net Income	(18.71 M)
	Cash And Equivalents	20.06 M
	Cash Per Share	0.58 X
	Total Debt	38.5 M
	Debt To Equity	0.02 %
	Current Ratio	4.45 X
	Book Value Per Share	0.43 X
	Cash Flow From Operations	(5.25 M)
	Short Ratio	11.17 X
	Earnings Per Share	(0.82) X
	Price To Earnings To Growth	(0.58) X
	Target Price	3.5
	Number Of Employees	252
	Beta	1.21
	Market Capitalization	40.71 M
	Total Asset	79.24 M
	Retained Earnings	(54.45 M)
	Working Capital	57.62 M
	Current Asset	10.01 M
	Current Liabilities	2.45 M
	Net Asset	79.24 M

About Apyx Medical Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Apyx Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Apyx Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Apyx Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

S	SentinelOne
MSFT	Microsoft
MSFT	Microsoft

Additional Tools for Apyx Stock Analysis

When running Apyx Medical's price analysis, check to measure Apyx Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Apyx Medical is operating at the current time. Most of Apyx Medical's value examination focuses on studying past and present price action to predict the probability of Apyx Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Apyx Medical's price. Additionally, you may evaluate how the addition of Apyx Medical to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC